Antifungal activity of 25-azalanosterol against Candida species

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 11, 2008, Pages 1131-1136

  Wang, J ^a   Wu, J ^b  

^a SHANXI UNIVERSITY   (China)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 AZALANOSTEROL; ANTIFUNGAL AGENT; CLOTRIMAZOLE; ERGOSTEROL; FLUCONAZOLE; LANOSTEROL DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; FUNGUS GROWTH; LIVER TOXICITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEROL SYNTHESIS;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; CELL LINE; HEPATOCYTES; HUMANS; INHIBITORY CONCENTRATION 50; LANOSTEROL; MICE; MICROBIAL SENSITIVITY TESTS; S-ADENOSYLMETHIONINE;

EID: 55549135336     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0554-y     Document Type: Article

References (24)

1. SS Long DK Stevenson 2005 Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis J Pediatr 147 135 141
2. CC Blyth P Palasanthiran TA O'Brien 2007 Antifungal therapy in children with invasive fungal infections: a systematic review Pediatrics 119 772 784
3. MA Pfaller PG Pappas JR Wingard 2006 Invasive fungal pathogens: current epidemiological trends Clin Infect Dis 43 S3 S14
4. PL Fidel Jr JA Vazquez JD Sobel 1999 Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans Clin Microbiol Rev 12 80 96
5. JE Hoppe 1997 Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal Pediatr Infect Dis J 16 885 894
6. CA Kauffman 2006 Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis Clin Infect Dis N Am 20 645 662
7. D Kaufman R Boyle KC Hazen JT Patrie M Robinson LB Grossman 2005 Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight J Pediatr 147 172 179
8. CK Kim KI Jeon DM Lim T Johng JM Trzaskos JL Gaylor YK Paik 1995 Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 14-reductase Biochim Biophys Acta 1259 39 48
9. R Kanagasabai WX Zhou JL Liu TT Nguyen P Veeramachaneni WD Nes 2004 Disruption of ergosterol biosynthesis, growth, and the morphological transition in Candida albicans by sterol methyltransferase inhibitors containing sulfur at C-25 in the sterol side chain Lipids 39 737 746
10. WX Zhou GI Lepesheva MR Waterman WD Nes 2006 Mechanistic analysis of a multiple product sterol methyltransferase implicated in ergosterol biosynthesis in Trypanosoma brucei J Biol Chem 281 6290 6296
11. ES Kaneshiro JA Rosenfeld M Basselin JR Stringer S Keely AG Smulian JL Giner 2002 The Pneumocystis carinii drug target S-adenosyl-L-methionine: sterol C-24 methyl transferase has a unique substrate preference Mol Microbiol 44 989 999
12. WX Zhou GA Cross WD Nes 2007 Cholesterol import fails to prevent catalyst-based inhibition of ergosterol synthesis and cell proliferation of Trypanosoma brucei J Lipid Res 26 665 673
13. JQ Wang JL Liu ZH Song WD Nes 2008 Sterol C24-methyltransferase: mechanistic studies of the C-methylation reaction with 24-fluorocycloartenol Bioorg Med Chem Lett 18 232 235
14. WD Nes P Jayasimha WX Zhou R Kanagasabai C Jin TT Jaradat RW Shaw JM Bujnicki 2004 Sterol methyltransferase: functional analysis of highly conserved residues by site-directed mutagenesis Biochemistry 43 569 576
15. A Arora H Raghuraman A Chattopadhyay 2004 Influence of cholesterol and ergosterol on membrane dynamics: a fluorescence approach Biochem Biophys Res Commun 318 920 926
16. R Deyes 2002 Cell viability assays Promega Notes 81 32 33
17. Nanotechnology Characterization Laboratory (NCL) (2006) HEP G2 hepatocarcinoma cytotoxicity assay. NCL Method GTA-2. SAIC-Frederick Inc. pp 3-7
18. Wang JQ, Nes WD (2008) Mechanism and scope of cyclobranol modulated 24-sterol methyltransferase catalysis enzyme inactivation and concurrent C24-alkylation and dealkylation. J Biol Chem (in Press)
19. DN Worsham M Basselin AG Smulian DH Beach ES Kaneshiro 2003 Evidence for cholesterol scavenging by Pneumocystis and potential modifications of host-synthesized sterols by the P. carinii SAM:SMT J Eukaryot Microbiol 50 678 679
20. PB Smith WJ Steinbach DK Benjamin Jr 2005 Neonatal candidiasis Infect Dis Clin North Am 19 603 615
21. TE Zaoutis K Heydon R Localio TJ Walsh C Feudtner 2007 Outcomes attributable to neonatal candidiasis Clin Infect Dis 44 1187 1193
22. ZH Song WX Zhou JL Liu WD Nes 2004 Mechanism-based active site modification of the soybean sterol methyltransferase by 26,27- dehydrocycloartenol Bioorg Med Chem Lett 14 33 36
23. FR Taylor RJ Rodriguez LW Parks 1983 Relationship between antifungal activity and inhibition of sterol biosynthesis in miconazole, clotrimazole, and 15-azasterol Antimicrob Agents Chemother 23 515 521
24. Borgers M, Van den Bossche H (1982) The mode of action of antifungal drugs. Ketoconazole in the management of fungal disease. Adis Press, New York, pp 25-47